Literature DB >> 28208909

Evaluation of Association of Hyperuricaemia with Metabolic Syndrome and Insulin Resistance.

Naveen Reddy Avula1, Damodar Shenoy2.   

Abstract

INTRODUCTION: The prevalence of Metabolic Syndrome (MetS) ranges from <10% to as much as 84% depending on region and composition of the population studied. The MetS is a growing public health problem in the world. AIM: To evaluate association of hyperuricaemia with components of MetS and insulin resistance.
MATERIALS AND METHODS: Sixty patients with MetS were conveniently recruited. MetS was defined as per Adult Treatment Panel III (ATP III) guidelines. For the purpose of analysis study participants were grouped into, group-I (controls - normal serum uric acid levels) and group-II (cases - hyperuricaemia). Hyperuricaemia was defined with cut-off >6.8mg/dl in both men and women. Associated work up for MetS and insulin resistance like fasting blood sugar, fasting lipid profile, fasting insulin, serum uric acid was done. Blood pressure and anthropometric measurements including weight, height and waist circumferences were measured and BMI was calculated. HOMA IR method was used to measure the degree of insulin resistance. Logistic regression analysis was used to evaluate association of hyperuricaemia with MetS and insulin resistance. Receiver Operating Curve (ROC) was plotted to find out optimum cut-off value for insulin resistance.
RESULTS: A significant increase in systolic blood pressure (p < 0.001) and triglyceride levels (p=0.027) were observed in hyperuricaemia subjects when compared to controls. After adjusting for potential confounders, Insulin resistance (HOMA IR >3.4) was independently associated with hyperuricaemia (OR=5.79, 95% CI=1.6- 20.69, p=0.007).
CONCLUSION: Insulin resistance beyond a threshold is independently associated with hyperuricaemia in subjects with MetS.

Entities:  

Keywords:  Homeostasis model assessment of insulin resistance; Public health problem; Serum uric acid

Year:  2016        PMID: 28208909      PMCID: PMC5296482          DOI: 10.7860/JCDR/2016/22182.9113

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  27 in total

1.  Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis.

Authors:  You-Jin Choi; Yujin Yoon; Kang-Yo Lee; Tran Thi Hien; Keon Wook Kang; Kyong-Cheol Kim; Jeewoo Lee; Moo-Yeol Lee; Seung Mi Lee; Duk-Hee Kang; Byung-Hoon Lee
Journal:  FASEB J       Date:  2014-03-20       Impact factor: 5.191

2.  Prevalence of hyperuricemia and the relationship between serum uric acid and metabolic syndrome in the Asian Mongolian area.

Authors:  Lili You; Aiping Liu; Gaowa Wuyun; Heping Wu; Peiyu Wang
Journal:  J Atheroscler Thromb       Date:  2014-01-07       Impact factor: 4.928

3.  Relationship between hyperuricemia and metabolic syndrome.

Authors:  Li-ying Chen; Wen-hua Zhu; Zhou-wen Chen; Hong-lei Dai; Jing-jing Ren; Jian-hua Chen; Lei-qian Chen; Li-zheng Fang
Journal:  J Zhejiang Univ Sci B       Date:  2007-08       Impact factor: 3.066

4.  Hyperuricaemia: relationships to body fat distribution and other components of the insulin resistance syndrome in 38-year-old healthy men and women.

Authors:  M Cigolini; G Targher; M Tonoli; F Manara; M Muggeo; G De Sandre
Journal:  Int J Obes Relat Metab Disord       Date:  1995-02

5.  Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators.

Authors:  M I Schmidt; R L Watson; B B Duncan; P Metcalf; F L Brancati; A R Sharrett; C E Davis; G Heiss
Journal:  Metabolism       Date:  1996-06       Impact factor: 8.694

6.  A longitudinal cohort based association study between uric acid level and metabolic syndrome in Chinese Han urban male population.

Authors:  Qian Zhang; Chengqi Zhang; Xinhong Song; Haiyan Lin; Dongzhi Zhang; Wenjia Meng; Yongyuan Zhang; Zhenxin Zhu; Fang Tang; Longjian Liu; Xiaowei Yang; Fuzhong Xue
Journal:  BMC Public Health       Date:  2012-06-08       Impact factor: 3.295

7.  Strategies for Primary Prevention of Coronary Heart Disease Based on Risk Stratification by the ACC/AHA Lipid Guidelines, ATP III Guidelines, Coronary Calcium Scoring, and C-Reactive Protein, and a Global Treat-All Strategy: A Comparative--Effectiveness Modeling Study.

Authors:  Benjamin Z Galper; Y Claire Wang; Andrew J Einstein
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

8.  The relationship between serum uric acid level and metabolic syndrome: differences by sex and age in Taiwanese.

Authors:  Wen-Ko Chiou; Ming-Hsu Wang; Ding-Hau Huang; Hsin-Tzu Chiu; Yun-Ju Lee; Jen-Der Lin
Journal:  J Epidemiol       Date:  2010-03-20       Impact factor: 3.211

Review 9.  Review of hyperuricemia as new marker for metabolic syndrome.

Authors:  Laura Billiet; Sarah Doaty; James D Katz; Manuel T Velasquez
Journal:  ISRN Rheumatol       Date:  2014-02-16

10.  Factors associated with no apparent coronary artery disease in patients with type 2 diabetes mellitus for more than 10 years of duration: a case control study.

Authors:  Mukund P Srinivasan; Padmanabh K Kamath; Narayan M Bhat; Narasimha D Pai; Poornima A Manjrekar; Chakrapani Mahabala
Journal:  Cardiovasc Diabetol       Date:  2015-10-31       Impact factor: 9.951

View more
  7 in total

1.  Lumbar epidural lipomatosis is associated with visceral fat and metabolic disorders.

Authors:  Shingo Morishita; Yoshiyasu Arai; Toshitaka Yoshii; Kenichiro Sakai; Takashi Hirai; Atsushi Okawa
Journal:  Eur Spine J       Date:  2018-05-02       Impact factor: 3.134

2.  Hyperuricemia and Its Associated Factors Among Adult Staff Members of the Ethiopian Public Health Institute, Ethiopia.

Authors:  Meseret Derbew Molla; Abebe Bekele; Daniel Seifu Melka; Maria Degef Teklemariam; Feyissa Challa; Birhanu Ayelign; Tewodros Shibabaw; Yonas Akalu; Zeleke Geto
Journal:  Int J Gen Med       Date:  2021-04-20

3.  The association between serum uric acid and features of metabolic disturbances in young adults.

Authors:  Sylwia Płaczkowska; Lilla Pawlik-Sobecka; Izabela Kokot; Agnieszka Piwowar
Journal:  Arch Med Sci       Date:  2020-03-12       Impact factor: 3.318

4.  Febuxostat attenuates ER stress mediated kidney injury in a rat model of hyperuricemic nephropathy.

Authors:  Li He; Ying Fan; Wenzhen Xiao; Teng Chen; Jiejun Wen; Yang Dong; Yiyun Wang; Shiqi Li; Rui Xue; Liyang Zheng; John Cijiang He; Niansong Wang
Journal:  Oncotarget       Date:  2017-11-30

5.  Safety and effectiveness of low-protein diet supplemented with ketoacids in diabetic patients with chronic kidney disease.

Authors:  Vincenzo Bellizzi; Patrizia Calella; Julia Nava Hernández; Verónica Figueroa González; Silvia Moran Lira; Serena Torraca; Rocio Urbina Arronte; Pietro Cirillo; Roberto Minutolo; Rafael A Montúfar Cárdenas
Journal:  BMC Nephrol       Date:  2018-05-09       Impact factor: 2.388

6.  Hyperuricemia in type 2 diabetic model KK-Ay/Ta mice: a potent animal model with positive correlation between insulin resistance and plasma high uric acid levels.

Authors:  Shin-Ichi Adachi; Fumiaki Yoshizawa; Kazumi Yagasaki
Journal:  BMC Res Notes       Date:  2017-11-07

7.  Influencing factors of glycemic variability in hospitalized type 2 diabetes patients with insulin therapy: A Strobe-compliant article.

Authors:  Ya Huang; Chunni Heng; Jing Wei; Xiaorui Jing; Xiaoguang Wang; Guohong Zhao; Junfeng Hou; Qingquan Liu; Kai Jiao
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.